Drug Induced Movement Disorders, Second Edition [#445534]

Drug Induced Movement Disorders, Second Edition By
2005 | 475 Pages | ISBN: 1405126191 | PDF | 4 MB
The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.Content: Chapter 1 Movement Disorders: an Overview (pages 3-19): Martin Cloutier and Anthony E. LangChapter 2 Rating Scales for Movement Disorders (pages 20-29): Ikwunga Wonodi, Elliot L. Hong, Matthew T. Avila and Gunvant K. ThakerChapter 3 Spontaneous Movement Disorders in Psychiatric Patients (pages 30-52): Irene Richard, Christopher O'Brien and Roger KurlanChapter 4 The Pharmacology of Typical and Atypical Antipsychotics (pages 55-71): Gary Remington and Shitij KapurChapter 5 Acute Drug?Induced Dystonia (pages 72-102): Michael F. Mazurek and Patricia I. RosebushChapter 6 Drug?Induced Parkinsonism (pages 103-139): Joseph H. Friedman, Martha E. Trieschmann and Hubert H. FernandezChapter 7 Acute Drug?Induced Akathisia (pages 140-173): Lenard A. Adler, John Rotrosen and Burt AngristChapter 8 Neuroleptic Malignant Syndrome (pages 174-212): Stewart A. FactorChapter 9 Tardive Dyskinesia (pages 213-256): Thomas M. Hyde, Jose A. Apud, Whitney C. Fisher and Michael F. EganChapter 10 Neuroleptic?Induced Tardive Dyskinesia Variants (pages 257-284): Frank Skidmore, William J. Weiner and Robert BurkeChapter 11 Movement Disorders Due to Atypical Antipsychotics (pages 285-301): Karen E. AndersonChapter 12 Commentary: Is Tardive Dyskinesia Disappearing? (pages 302-310): James B. LohrChapter 13 Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease (pages 313-350): John G. Nutt and Matthew A. BrodskyChapter 14 Movement Disorders and Dopaminomimetic Stimulant Drugs (pages 351-370): Anthony E. Munson, Juan Sanchez?Ramos and William J. WeinerChapter 15 Antidepressants (pages 373-407): Maria L. Moro?de?Casillas and David E. RileyChapter 16 Antiepileptics (pages 408-429): John C. Morgan and Madaline B. HarrisonChapter 17 Miscellaneous Drug?Induced Movement Disorders (pages 430-441): Daniel Tarsy